Glenmark Generics follows Glenmark Pharma: Trilegal, A&O and Amarchand advise IPO

Bar&Bench News Network

Oct 06, 2009

Trilegal's Mumbai office is advising Glenmark Generics (GG) to raise Rs. 570 Crore ($118 Million) through an IPO, valuing GG at about Rs. 4,800 Crores ($ 1 Billion). Glenmark Generics' parent company, Glenmark Pharma (GP), and its affiliates own about 97 percent in GG.

GG's parent company, Glenmark Pharma, is one of Trilegal's long-standing clients. The Trilegal team was led by Partner Amit Tambe, assisted by Associates Ajit Sharma, and Sriram Ramachandran. Marshall Mendoza, VP (Legal and Company Secretary) was GG's in-house legal advisor to the issue. Amarchand Mangaldas advised the underwriters on the domestic law. Continuing a profitable alliance, 'best friend' Allen & Overy were in on the deal as international advisers to the underwriters.

Glenmark Pharma, which went the QIP route a fortnight ago, was advised by the same set of legal advisers, in identical roles.

 

Add to My Clips Print this Story Email this Story

 

Facebook LinkedIn MySpace Digg Del.icio.us twitter

Comments(0)




Be the first to post a comment 

Post Your Comment

Name* :

Location :

Email Id :

Comment * :

Notify me when there is a comment


 

Thank you. Comments are subject to moderation.